EMPOWER

EMPOWER is a multi-centre, double-masked, randomized controlled trial designed to determine if the administration of Domperidone compared to placebo will increase breast milk production without any signs of harm over a two or four week period.

The primary research question asks: In mothers of preterm infants 23 0/7 to 29 6/7 completed weeks gestation at birth who are pumping to provide expressed breast milk for their infant(s) and are identified as having an inadequate milk supply, does the administration of Domperidone compared to placebo increase breast milk volume without any signs of harm over a two or four week period?

The sample size for EMPOWER is 560 mothers (280/group), to be recruited from approximately 20 Canadian and International centres.

For more information on the EMPOWER trial, please contact: empower@sunnybrook.ca.

Comments & Responses

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>